Stocks and Investing
Stocks and Investing
Wed, May 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, May 17, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (VIGL) at Hold with Decreased Target to $11 on, May 17th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Vigil Neuroscience, Inc." (VIGL) at Hold with Decreased Target from $17 to $11 on, May 17th, 2022.
Matthew has made no other calls on VIGL in the last 4 months.
There are 2 other peers that have a rating on VIGL. Out of the 2 peers that are also analyzing VIGL, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $20 on, Tuesday, February 1st, 2022
- Paul Matteis of "Stifel" Initiated at Strong Buy and Held Target at $24 on, Tuesday, February 1st, 2022
Contributing Sources